Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRS | MCK | BDX | CAH | WST |
| Company | Antares Pharma | Mckesson Corp | Becton Dickinson and Company | Cardinal Health | West Pharmaceutical Services |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 5.58 | 579.96 | 226.34 | 118.28 | 330.08 |
| High | 5.60 | 579.96 | 227.87 | 118.78 | 330.68 |
| Low | 5.58 | 569.63 | 225.30 | 116.69 | 325.33 |
| Last | 5.59 | 576.76 | 226.44 | 118.35 | 329.57 |
| Change | unch | -2.98 | -1.24 | +0.07 | -1.83 |
| % Change | unch | -0.51% | -0.54% | +0.06% | -0.55% |
| Volume | 2,707,400 | 517,106 | 1,783,653 | 1,514,195 | 374,165 |
| 20-Day Average Volume | 3,885,230 | 904,330 | 2,392,865 | 2,305,045 | 520,820 |
| Previous Close | 5.59 | 579.74 | 227.68 | 118.28 | 331.40 |
| Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 595.33 | 223.74 | 120.13 | 324.70 |
| 20-Day Raw Stochastic | 83.33% | 25.43% | 58.91% | 32.24% | 65.00% |
| 20-Day Relative Strength | 76.57% | 48.72% | 49.03% | 50.46% | 55.05% |
| Weighted Alpha | +30.00 | +19.85 | -7.36 | +18.80 | -4.33 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Sell | 72% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Sell | 72% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 56% Buy | 72% Sell | 100% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 05/16/22 | +1.17% since 12/16/24 | -0.49% since 12/16/24 | +1.54% since 12/16/24 | -0.30% since 12/16/24 |
| Low | 5.57 on 05/18/22 | 558.13 on 12/17/24 | 222.82 on 12/19/24 | 114.60 on 12/17/24 | 319.74 on 12/19/24 |
| High | 5.60 on 05/23/22 | 583.93 on 12/20/24 | 229.31 on 12/20/24 | 118.86 on 12/20/24 | 337.20 on 12/17/24 |
| 1-Month | |||||
| %Chg | +0.36% since 04/22/22 | -7.45% since 11/22/24 | +1.09% since 11/22/24 | -2.86% since 11/22/24 | +4.10% since 11/22/24 |
| Low | 5.54 on 05/12/22 | 558.13 on 12/17/24 | 218.84 on 12/11/24 | 114.60 on 12/17/24 | 313.92 on 12/05/24 |
| High | 5.60 on 05/23/22 | 631.40 on 11/27/24 | 231.74 on 12/16/24 | 126.23 on 12/04/24 | 338.00 on 12/16/24 |
| 3-Month | |||||
| %Chg | +65.88% since 02/23/22 | +14.21% since 09/23/24 | -3.53% since 09/23/24 | +5.82% since 09/23/24 | +7.45% since 09/23/24 |
| Low | 3.24 on 02/24/22 | 464.42 on 09/24/24 | 218.84 on 12/11/24 | 106.54 on 09/25/24 | 281.00 on 10/09/24 |
| High | 5.60 on 05/23/22 | 632.59 on 11/22/24 | 244.50 on 10/15/24 | 126.23 on 12/04/24 | 352.33 on 10/24/24 |
| 6-Month | |||||
| %Chg | +63.93% since 11/23/21 | -4.36% since 06/21/24 | -4.97% since 06/21/24 | +13.11% since 06/21/24 | -0.96% since 06/21/24 |
| Low | 3.11 on 01/28/22 | 464.42 on 09/24/24 | 218.75 on 07/10/24 | 93.17 on 07/15/24 | 265.00 on 07/25/24 |
| High | 5.60 on 05/23/22 | 637.51 on 08/02/24 | 244.98 on 09/03/24 | 126.23 on 12/04/24 | 352.33 on 10/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,063 | 73,592,192 | 66,029,020 | 28,624,942 | 24,000,648 |
| Shares Outstanding, K | 170,852 | 126,940 | 290,008 | 242,010 | 72,422 |
| Annual Sales | 183,980,000 | 308,951,000,000 | 20,178,000,000 | 226,827,000,000 | 2,949,800,000 |
| Annual Net Income | 46,290,000 | 3,002,000,000 | 1,705,000,000 | 852,000,000 | 593,400,000 |
| Last Quarter Sales | 41,560,000 | 93,651,000,000 | 5,437,000,000 | 52,277,000,000 | 746,900,000 |
| Last Quarter Net Income | -2,320,000 | 241,000,000 | 400,000,000 | 416,000,000 | 136,000,000 |
| 60-Month Beta | 1.15 | 0.49 | 0.41 | 0.61 | 1.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/10/22 | 7.07 on 11/06/24 | 3.81 on 11/07/24 | 1.88 on 11/01/24 | 1.85 on 10/24/24 |
| Latest Earnings Date | 05/19/22 | 02/05/25 | 02/06/25 | 01/30/25 | 10/24/24 |
| Most Recent Dividend | N/A | 0.710 on 12/02/24 | 1.040 on 12/09/24 | 0.506 on 10/01/24 | 0.210 on 11/13/24 |
| Next Ex-Dividends Date | N/A | 12/02/24 | 12/09/24 | 01/02/25 | 11/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 79.86 | 20.08 | 17.30 | 15.52 | 49.02 |